Pressure BioSciences, Inc. (PBIO) Shares Rebound Over 7%
After an inexplicable sell off, PBIO shares rebounded strong. The falling share price has been attributed by many to have been caused by confusion linking Pressure BioSciences, Inc. and Panacos Pharmaceuticals Inc. which neared its 52 week low after disappointing results. Previously Pressure BioSciences had a position in Panacos Pharmaceuticals, but sold off all its interest over six months ago. The Company has attracted the attention of several analysts and has been awarded 12-month price targets as high as $10 – a near double from the current price. The most recent report published by Dutton Associates on December 18 detailed that…